Silvia Vicenzi/LinkedIn
Dec 29, 2025, 23:55
Silvia Vicenzi: From a Hormone-Centric Model to an Immune-Centric Understanding of the Disease
Silvia Vicenzi, Business Development Manager at Biocytogen, posted on LinkedIn:
“The kind of science we need more of: rigorous, human, and deeply purpose-driven. The latest Science feature on endometriosis research highlights a critical shift in the field: from a hormone-centric model to an immune-centric understanding of the disease.
Emerging data show that endometriotic lesions are shaped by:
- immune dysregulation (macrophage activation, altered NK cell function)
- chronic inflammatory signaling (IL-6, TNF-α, prostaglandins)
- aberrant tissue remodeling and angiogenesis
- immune–epithelial cross-talk driving lesion persistence
This reframes endometriosis as a complex immuno-inflammatory disorder, not just a reproductive one.
Why this matters:
- It opens the door to non-hormonal interventions that target pathways like inflammation, cytokine signaling, or immune cell recruitment.
- It supports development of diagnostic biomarkers based on immune signatures instead of invasive surgery.
- It aligns endometriosis with broader patterns seen in autoimmune-adjacent diseases.
Women’s health research is finally gaining the scientific attention it deserves — and immunology is at the center of that shift.
If you want to read the entire article here.”
Get insights from Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination